Could high ferritin be iron overload or hemochromatosis?

High ferritin can indicate iron overload or hemochromatosis, but also inflammation, liver disease, or other conditions. Genetic testing and additional iron studies help distinguish hereditary hemochromatosis from other causes of elevated ferritin.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Finding out you have high ferritin levels can be concerning, especially when you start reading about iron overload and hemochromatosis. While elevated ferritin often does indicate excess iron in your body, it's not always a straightforward diagnosis. Understanding what ferritin measures, what causes it to rise, and how doctors distinguish between different conditions can help you navigate your health journey with confidence.

Ferritin is a protein that stores iron in your cells, and measuring it gives doctors insight into your body's iron reserves. But here's where it gets complex: ferritin isn't just an iron storage marker. It's also an acute-phase reactant, meaning it rises during inflammation, infection, or other stressors. This dual role makes interpreting high ferritin levels more nuanced than simply concluding you have too much iron.

Understanding Ferritin and Its Role in Your Body

Ferritin acts as your body's iron savings account. When you consume iron through food or supplements, your body stores excess amounts in ferritin molecules, primarily in your liver, spleen, and bone marrow. This storage system allows your body to maintain steady iron levels for essential functions like making red blood cells, supporting immune function, and producing energy.

Interpreting Ferritin Levels

Ferritin Level (ng/mL)InterpretationPossible CausesNext Steps
<12<12Iron deficiencyBlood loss, poor absorption, inadequate intakeIron supplementation, investigate cause
12-15012-150Normal rangeHealthy iron storesContinue monitoring annually
150-300150-300Mildly elevatedEarly iron overload, inflammation, liver diseaseCheck full iron panel, inflammatory markers
300-1000300-1000Moderately elevatedIron overload, chronic inflammation, metabolic syndromeComprehensive testing, consider genetic testing
>1000>1000Severely elevatedHemochromatosis, liver disease, frequent transfusionsUrgent evaluation, start treatment

Ferritin interpretation requires context from additional tests and clinical symptoms.

Normal ferritin levels vary by age and sex, but generally range from 12-300 ng/mL for men and 12-150 ng/mL for women. However, optimal levels for health may be narrower than these reference ranges. Many functional medicine practitioners suggest aiming for ferritin levels between 50-150 ng/mL, as both very low and very high levels can impact your health.

Why Ferritin Testing Matters

Regular ferritin testing can catch iron imbalances before they cause serious problems. Low ferritin indicates iron deficiency, which can lead to anemia, fatigue, and impaired cognitive function. High ferritin, on the other hand, might signal iron overload, inflammation, or other underlying conditions that need attention. Monitoring your ferritin levels helps you maintain optimal iron balance for energy, immunity, and overall health.

What Causes High Ferritin Levels?

When ferritin levels climb above normal, several culprits could be responsible. Understanding these different causes helps explain why a single high ferritin reading doesn't automatically mean you have hemochromatosis or iron overload.

Iron Overload Conditions

True iron overload occurs when your body absorbs and stores more iron than it needs. This can happen through:

  • Hereditary hemochromatosis - a genetic condition causing excessive iron absorption
  • Secondary iron overload from frequent blood transfusions
  • Excessive iron supplementation
  • Certain liver diseases that impair iron regulation

Many conditions can elevate ferritin without actual iron overload:

  • Inflammation from infections, autoimmune diseases, or chronic conditions
  • Liver disease, including fatty liver disease and hepatitis
  • Metabolic syndrome and obesity
  • Alcohol consumption
  • Certain cancers
  • Hyperthyroidism

This is why doctors rarely diagnose iron overload based on ferritin alone. They need additional tests to determine whether high ferritin truly reflects excess iron stores.

Hemochromatosis: When Your Body Stores Too Much Iron

Hemochromatosis is a genetic disorder that causes your body to absorb too much iron from food. Unlike secondary iron overload, which develops from external factors, hereditary hemochromatosis stems from mutations in genes that regulate iron absorption, most commonly the HFE gene.

The condition affects approximately 1 in 200-300 people of Northern European descent, making it one of the most common genetic disorders. However, not everyone with the genetic mutations develops symptoms or iron overload. This incomplete penetrance means that having the genes doesn't guarantee you'll develop the disease.

Types of Hemochromatosis

There are several types of hemochromatosis, classified by the genetic mutations involved:

  • Type 1 (HFE-related) - The most common form, caused by C282Y and H63D mutations
  • Type 2 (Juvenile hemochromatosis) - Rare, severe form appearing before age 30
  • Type 3 - Caused by transferrin receptor 2 mutations
  • Type 4 (Ferroportin disease) - Affects iron export from cells

Recognizing the Signs and Symptoms

Iron overload develops slowly, and early symptoms often mimic other common conditions. This makes diagnosis challenging, as many people attribute their symptoms to aging, stress, or other health issues.

Early Warning Signs

In the early stages, iron overload may cause:

  • Chronic fatigue and weakness
  • Joint pain, especially in the hands
  • Abdominal pain
  • Loss of sex drive or erectile dysfunction
  • Brain fog and memory problems
  • Mood changes, including depression and irritability

Advanced Symptoms

Without treatment, iron accumulation can damage organs and cause:

  • Liver cirrhosis or cancer
  • Diabetes (bronze diabetes)
  • Heart problems, including arrhythmias and heart failure
  • Arthritis and joint damage
  • Skin darkening or bronze discoloration
  • Hormone imbalances affecting thyroid and reproductive function

The good news is that early detection and treatment can prevent these complications entirely. Regular monitoring of iron markers helps catch problems before organ damage occurs.

Getting the Right Tests: Beyond Ferritin

While ferritin is an important screening tool, diagnosing iron overload or hemochromatosis requires a comprehensive panel of tests. These additional markers help distinguish true iron overload from other causes of high ferritin.

Essential Iron Studies

A complete iron panel includes:

  • Serum iron - Measures iron circulating in your blood
  • Total iron-binding capacity (TIBC) - Shows how much iron your blood can carry
  • Transferrin saturation - The percentage of transferrin carrying iron (key for hemochromatosis)
  • Transferrin - The protein that transports iron

Transferrin saturation is particularly important for diagnosing hemochromatosis. Values above 45% in men or 40% in women suggest increased iron absorption and warrant further investigation. When combined with elevated ferritin, high transferrin saturation strongly indicates iron overload.

Genetic Testing

If iron studies suggest hemochromatosis, genetic testing can confirm the diagnosis. The HFE gene test looks for the C282Y and H63D mutations. Having two copies of C282Y (homozygous) carries the highest risk for iron overload, while other combinations have variable penetrance.

Additional tests may include liver function tests, imaging studies to assess iron deposits in organs, and sometimes liver biopsy for definitive diagnosis. Regular monitoring through comprehensive testing helps track your iron status and guide treatment decisions.

Treatment Options: Managing Iron Levels

The treatment for high ferritin depends entirely on the underlying cause. For true iron overload and hemochromatosis, the goal is reducing iron stores to normal levels and preventing reaccumulation.

Therapeutic Phlebotomy

The primary treatment for hemochromatosis is therapeutic phlebotomy - essentially donating blood to remove excess iron. During the initial phase, you might need weekly or biweekly phlebotomies until ferritin drops below 50-100 ng/mL. Maintenance therapy then continues every 2-4 months to keep iron levels stable.

Each phlebotomy removes about 200-250 mg of iron, and most people tolerate the procedure well. Some experience temporary fatigue or dizziness, but these effects typically resolve quickly.

Dietary Modifications

While diet alone can't treat hemochromatosis, certain modifications support treatment:

  • Avoid iron supplements and multivitamins containing iron
  • Limit vitamin C supplements (increases iron absorption)
  • Reduce alcohol consumption (stresses the liver)
  • Avoid raw shellfish (higher infection risk with iron overload)
  • Consider drinking tea or coffee with meals (tannins reduce iron absorption)

For elevated ferritin without iron overload, treatment focuses on addressing the underlying cause - managing inflammation, treating liver disease, or improving metabolic health.

Living Well with Iron Overload

A diagnosis of hemochromatosis or iron overload isn't a life sentence. With proper management, most people live normal, healthy lives. The key is early detection, consistent treatment, and regular monitoring.

Many people find that treatment actually improves their quality of life dramatically. Fatigue lifts, joint pain improves, and the risk of serious complications drops significantly. Some even become regular blood donors, turning their condition into an opportunity to help others.

Family screening is crucial if you're diagnosed with hereditary hemochromatosis. First-degree relatives (parents, siblings, children) should undergo genetic testing and iron studies, as early detection prevents complications.

Taking Control of Your Iron Health

High ferritin levels deserve attention, but they don't always mean you have hemochromatosis or dangerous iron overload. The key is getting comprehensive testing to understand what's driving your elevated levels. Whether it's true iron overload, inflammation, or another condition, identifying the cause empowers you to take appropriate action.

Remember that iron metabolism is complex, and your body's needs can change over time. Regular monitoring helps you maintain optimal iron balance, supporting everything from energy production to immune function. If you're concerned about your ferritin levels or have a family history of hemochromatosis, don't wait for symptoms to worsen. Early testing and intervention make all the difference in preventing complications and maintaining vibrant health.

By understanding your iron status and working with healthcare providers who recognize the nuances of ferritin interpretation, you can navigate high ferritin levels confidently. Whether you need therapeutic phlebotomy, dietary changes, or treatment for an underlying condition, the path forward becomes clear once you have the right information.

References

  1. Adams, P. C., Reboussin, D. M., Barton, J. C., McLaren, C. E., Eckfeldt, J. H., McLaren, G. D., ... & Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators. (2005). Hemochromatosis and iron-overload screening in a racially diverse population. New England Journal of Medicine, 352(17), 1769-1778.[Link][PubMed][DOI]
  2. Bacon, B. R., Adams, P. C., Kowdley, K. V., Powell, L. W., & Tavill, A. S. (2011). Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology, 54(1), 328-343.[Link][PubMed][DOI]
  3. Brissot, P., Pietrangelo, A., Adams, P. C., de Graaff, B., McLaren, C. E., & Loréal, O. (2018). Haemochromatosis. Nature Reviews Disease Primers, 4(1), 1-15.[Link][PubMed][DOI]
  4. Kowdley, K. V., Brown, K. E., Ahn, J., & Sundaram, V. (2019). ACG clinical guideline: hereditary hemochromatosis. American Journal of Gastroenterology, 114(8), 1202-1218.[Link][PubMed][DOI]
  5. Knovich, M. A., Storey, J. A., Coffman, L. G., Torti, S. V., & Torti, F. M. (2009). Ferritin for the clinician. Blood Reviews, 23(3), 95-104.[Link][PubMed][DOI]
  6. Palmer, W. C., Vishnu, P., Sanchez, W., Aqel, B., Riegert-Johnson, D., Seaman, L. A., ... & Bowman, A. W. (2018). Diagnosis and management of genetic iron overload disorders. Journal of General Internal Medicine, 33(12), 2230-2236.[Link][PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my ferritin at home?

You can test your ferritin at home with SiPhox Health's Core Health Program, which includes ferritin testing along with other essential biomarkers. This CLIA-certified program provides lab-quality results from the comfort of your home, with personalized insights to help you understand and optimize your iron levels.

What's the difference between iron overload and hemochromatosis?

Iron overload is a general term for excess iron in the body from any cause, including frequent transfusions or excessive supplementation. Hemochromatosis specifically refers to genetic conditions causing increased iron absorption. While hemochromatosis leads to iron overload, not all iron overload is due to hemochromatosis.

Can high ferritin levels be reversed?

Yes, high ferritin levels can often be reversed with appropriate treatment. For iron overload, therapeutic phlebotomy effectively reduces iron stores. For elevated ferritin due to inflammation or other causes, treating the underlying condition typically normalizes levels. The key is identifying the root cause through comprehensive testing.

Should I avoid iron-rich foods if my ferritin is high?

If you have confirmed iron overload or hemochromatosis, you don't need to eliminate iron-rich foods entirely, but should avoid iron supplements and limit vitamin C with meals. However, if high ferritin is due to inflammation rather than iron overload, dietary iron restriction isn't necessary and could be harmful.

How often should I monitor my ferritin levels?

Monitoring frequency depends on your situation. During active treatment for iron overload, testing may occur monthly. For maintenance, every 3-6 months is typical. If you have risk factors or family history but normal levels, annual testing is reasonable. Regular monitoring helps catch changes early and adjust treatment as needed.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details